Multimeric Elp Fusion Constructs
Phasebio Pharmaceuticals, Inc.
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 7,709,227 | Multimeric Elp Fusion Constructs In force · High confidence | Phasebio Pharmaceuticals, Inc. | In force | High confidence | ||
| Application 12/712,615 | Multimeric Elp Fusion Constructs Abandoned Abandoned Aug 12, 2011 | Phasebio Pharmaceuticals, Inc. | Abandoned | Abandoned Aug 12, 2011 |
2 of 2 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
1 of these is in force and held by Phasebio Pharmaceuticals, Inc..
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.